MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 28, 2006; DOI: 10.1124/mol.106.030445


0026-895X/07/7103-769-776$20.00
Mol Pharmacol 71:769-776, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.030445v1
71/3/769    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tapia, L.
Right arrow Articles by Lindstrom, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tapia, L.
Right arrow Articles by Lindstrom, J.

Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors

L. Tapia, A. Kuryatov, and J. Lindstrom

Departmento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain (L.T.); and Department of Neuroscience, University of Pennsylvania Medical School, Philadelphia, Pennsylvania (A.K., J.L.)

Human {alpha}4beta2 nicotinic acetylcholine receptors (AChRs) expressed in Xenopus laevis oocytes or transfected cell lines are present as a mixture of two stoichiometries, ({alpha}4)2(beta2)3 and ({alpha}4)3(beta2)2, which differ depending on whether a beta2 or {alpha}4 subunit occupies the accessory subunit position corresponding to beta1 subunits of muscle AChRs. Pure populations of each stoichiometry can be expressed in oocytes by combining a linked pair of {alpha}4 and beta2 with free beta2 to produce the ({alpha}4)2(beta2)3 stoichiometry or with free {alpha}4 to produce the ({alpha}4)3(beta2)2 stoichiometry. We show that the ({alpha}4)3(beta2)2 stoichiometry and the ({alpha}4)2(beta2)2beta3 and ({alpha}4)2(beta2)2{alpha}5 subtypes in which beta3 or {alpha}5occupy the accessory positions have much higher permeability to Ca2+ than does ({alpha}4)2(beta2)3 and suggest that this could be physiologically significant in triggering signaling cascades if this stoichiometry or these subtypes were found in vivo. We show that Ca2+ permeability is determined by charged amino acids at the extracellular end of the M2 transmembrane domain, which could form a ring of amino acids at the outer end of the cation channel. {alpha}4, {alpha}5, and beta3 subunits all have a homologous glutamate in M2 that contributes to high Ca2+ permeability, whereas beta2 has a lysine at this position. Subunit combinations or single amino acids changes at this ring that have all negative charges or a mixture of positive and negative charged amino acids are permeable to Ca2+. All positive charges in the ring prevent Ca2+ permeability. Increasing the proportion of negative charges is associated with increasing permeability to Ca2+.


Received September 5, 2006; accepted November 28, 2006

Address correspondence to: Dr. Jon Lindstrom, Department of Neuroscience, University of Pennsylvania Medical School, 217 Stemmler Hall, 36th and Hamilton Walk, Philadelphia, PA 19104. E-mail: jslkk{at}mail.med.upenn.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters
Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor
J. Biol. Chem., July 11, 2008; 283(28): 19301 - 19313.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez
Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation
J. Neurosci., July 2, 2008; 28(27): 6884 - 6894.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Onksen, and J. Lindstrom
Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors
Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. LINDSTROM, J. LUO, and A. KURYATOV
Myasthenia Gravis and the Tops and Bottoms of AChRs: Antigenic Structure of the MIR and Specific Immunosuppression of EAMG Using AChR Cytoplasmic Domains
Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks
Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits
Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zwart, A. L. Carbone, M. Moroni, I. Bermudez, A. J. Mogg, E. A. Folly, L. M. Broad, A. C. Williams, D. Zhang, C. Ding, et al.
Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant {alpha}4{beta}2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., June 1, 2008; 73(6): 1838 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester
Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits
Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics